C‑C motif chemokine 14 as a novel potential biomarker for predicting the prognosis of epithelial ovarian cancer
Authors:
Open Access
- 7 February 2020
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 19 (4) , 2875-2883
Abstract
Previous studies have demonstrated that C‑C motif chemokine 14 (CCL14) plays an important role in the occurrence and development of cancer. However, the significance of CCL14 in the progression and prognosis of epithelial ovarian cancer (EOC) has not yet been reported. The standard EnVision procedure for tissue microarrays was used to evaluate the immunohistochemical expression of CCL14 protein in 154 patients with EOC who underwent tumor‑debulking operations at the Central Cancer Department of Sun Yat‑Sen University (Guangzhou, China) or Jiangmen Central Hospital (Jiangmen, China). The association between CCL14 expression and clinicopathological variables was assessed using the χ2 test. For survival status of patients with EOC, Kaplan‑Meier survival analysis and a Cox multivariate regression model was used. Expression of CCL14 protein was significantly associated with International Federation of Gynecology and Obstetric stage (P=0.014) and pN status(P=0.005). Kaplan‑Meier survival analysis revealed that the survival time of patients with high expression of CCL14 was 136.1 months and that of patients with low expression of CCL14 was 98.9 months (P=0.026). Multivariate analysis demonstrated that CCL14 upregulation was associated with overall survival time (HR, 0.48; 95% CI, 0.261‑0.896; P=0.021) and progression‑free survival time (HR,0.437; 95% CI, 0.228‑0.839; P=0.013). In conclusion, CCL14 is an independent prognostic factor for EOC and upregulation of CCL14 is associated with a more favorable prognosis in patients with EOC.Keywords
This publication has 44 references indexed in Scilit:
- Overexpression of ZEB2 in Peritumoral Liver Tissue Correlates with Favorable Survival after Curative Resection of Hepatocellular CarcinomaPLOS ONE, 2012
- Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesisPathology, 2011
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinomaCancer Science, 2010
- A novel role for constitutively expressed epithelial-derived chemokines as antibacterial peptides in the intestinal mucosaMucosal Immunology, 2009
- EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentaryEuropean Journal of Cancer, 2009
- Reduced local immunity in HPV‐related VIN: Expression of chemokines and involvement of immunocompetent cellsInternational Journal of Cancer, 2008
- Hemofiltrate CC Chemokine 1[9-74] Causes Effective Internalization of CCR5 and Is a Potent Inhibitor of R5-Tropic Human Immunodeficiency Virus Type 1 Strains in Primary T Cells and MacrophagesAntimicrobial Agents and Chemotherapy, 2002
- Natural Proteolytic Processing of Hemofiltrate Cc Chemokine 1 Generates a Potent Cc Chemokine Receptor (Ccr)1 and Ccr5 Agonist with Anti-HIV PropertiesJournal of Experimental Medicine, 2000
- HCC-1, a novel chemokine from human plasma.Journal of Experimental Medicine, 1996